Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05042232 · ClinicalTrials.gov registry record
A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19
A clinical trial of SARS-CoV-2 Acute Respiratory Disease, sponsored by Everly Health.
- Completed
- Registry status
- 239
- Enrollment target
- 1
- Study location
NCT05042232 is a study of SARS-CoV-2 Acute Respiratory Disease that has completed, run by Everly Health. The registered enrollment target is 239 participants, below the 567-participant average among 3 other SARS-CoV-2 Acute Respiratory Disease trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05042232, a study of SARS-CoV-2 Acute Respiratory Disease, has completed, sponsored by Everly Health.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.
Conditions Studied
Interventions
- OTHER SARS-CoV-2 Positive
- OTHER SARS-CoV-2 Negative
Study Locations (1)
Texas
- Everlywell, Inc - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05042232
The ClinicalTrials.gov registry entry for NCT05042232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 567-participant average among 3 other SARS-CoV-2 Acute Respiratory Disease trials with a reported enrollment target (58% lower). The listed sponsor is Everly Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SARS-CoV-2 Acute Respiratory Disease appearing as the primary indexed condition, and to 2 interventions - of which SARS-CoV-2 Positive is the first listed.
NCT05042232 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05042232 about?
NCT05042232 is a clinical study titled "A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19". The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.
What is the current status of trial NCT05042232?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2021-04-19. Estimated completion is 2022-06-14.
What conditions does trial NCT05042232 study?
This clinical trial studies the following conditions: SARS-CoV-2 Acute Respiratory Disease.
What interventions are being tested in trial NCT05042232?
The interventions under investigation include: SARS-CoV-2 Positive (OTHER), SARS-CoV-2 Negative (OTHER).
Who is sponsoring clinical trial NCT05042232?
This trial is sponsored by Everly Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05042232 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SARS-CoV-2 Acute Respiratory Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
ACTIVE NOT RECRUITING · NA
-
A Retrospective Study of COVID-19 Treatments
COMPLETED
-
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.